Ειδήσεις: WEISS RATINGS | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

01/04 11:43 defenseworld.net

Corporacion Inmobiliaria Vesta, S.A.B. de C.V. Sponsored ADR (NYSE:VTMX) Receives Average Recommendation of “Hold” from Brokerages

Vesta ADR hold buy Scotiabank Weiss Ratings

01/04 11:43 defenseworld.net

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Given Average Recommendation of “Moderate Buy” by Brokerages

Zai Lab ADR Nasdaq broker ratings Moderate Buy price target

01/04 10:41 defenseworld.net

Cullen/Frost Bankers (NYSE:CFR) Price Target Lowered to $133.00 at Morgan Stanley

Cullen/Frost Bankers price target Morgan Stanley Cantor Fitzgerald Weiss Ratings RBC

01/04 10:26 defenseworld.net

Aprea Therapeutics (NASDAQ:APRE) Given Outperform Rating at Wedbush

Aprea Therapeutics APRE analyst ratings Wedbush HC Wainwright Zacks

01/04 10:21 defenseworld.net

Talos Energy (NYSE:TALO) Price Target Raised to $20.00 at Citigroup

Talos Energy Citigroup price target buy rating KeyCorp Weiss Ratings

01/04 10:16 defenseworld.net

Bicara Therapeutics (NASDAQ:BCAX) Price Target Raised to $42.00 at HC Wainwright

Bicara Therapeutics price target HC Wainwright analyst ratings Citigroup Weiss Ratings

01/04 09:56 defenseworld.net

IDEAYA Biosciences (NASDAQ:IDYA) Receives Outperform Rating from Wedbush

IDEAYA Biosciences IDYA Wedbush Cantor Fitzgerald Wall Street Zen UBS Group

01/04 09:45 defenseworld.net

BTCS (NASDAQ:BTCS) Price Target Cut to $5.00 by Analysts at HC Wainwright

BTCS price target HC Wainwright Wall Street Zen Weiss Ratings consensus rating

01/04 09:45 defenseworld.net

Knightscope (NASDAQ:KSCP) Receives “Buy” Rating from HC Wainwright

Knightscope HC Wainwright Ascendiant Capital Wall Street Zen Weiss Ratings buy rating

01/04 09:45 defenseworld.net

Knightscope (NASDAQ:KSCP) Receives “Buy” Rating from HC Wainwright

Knightscope HC Wainwright Ascendiant Capital Wall Street Zen Weiss Ratings buy rating

Loading...